Eli Lilly Leads IDEA Pharma Rankings
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Eli Lilly achieved the No. 1 spot in both the innovation and invention categories of IDEA Pharma’s pharmaceutical R&D performance ranking.
- IDEA Pharma, a UK‑based consultancy within SAI MedPartners, compiled the ranking using criteria such as revenue from new products, new drug approvals, and major development events for innovation.
- IDEA Pharma also evaluated invention based on the number of drugs in development, clinical trial activity, and R&D investment.
- Eli Lilly is the first company ever to top both categories in the same ranking.
Why it matters: Investors and competitors watch the ranking, as Lilly’s dual leadership attracts capital and pressures rivals to boost R&D spend, potentially reshaping market share and industry dynamics.
Ask SkimNews
